QT Imaging Holdings Inc. (QTI)
QTI trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1844505/000162828026020909/0001628280-26-020909-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | QTI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001844505 |
| SEC industry code | Electromedical & Electrotherapeutic Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $18.9M |
| Net income | -$21.1M |
| Operating income | -$4.4M |
| Net margin | -111.4% |
| Operating margin | -23.4% |
| Revenue growth | +287.9% |
| Cash | $10.4M |
| Total assets | $23.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-10 |
| Cash and burn | $8.1M cash; operating cash flow -$3.4M a quarter. | Report 2026-09-30 |
| Shares outstanding | 14,692,216 (2026-11-09); 11,902,198 a year earlier; 8,659,978 three years earlier. 3y figure adjusted for splits (1-for-15 overall). | Cover page 2026-11-09 |
| Reverse splits, 3 years | 2; latest 1-for-5 on 2025-10-27 | Source 2025-10-27 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the market | Latest 2026-05-15 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2025-07-21 |
| Auditor | BPM LLP, San Jose, California, United States | PCAOB Form AP 2026-03-30 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $155K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $7.3M | -$297K | -$2.2M | $8.1M | $11.4M | $29.6M | 10-Q 2026-11-10 |
| Q2 2026 2026-06-30 | $7.4M | -$11.1M | -$4.8M | $10.9M | $11.4M | $26.4M | 10-Q 2026-08-12 |
| Q1 2026 2026-03-31 | $6.5M | -$3.4M | -$3.7M | $6.9M | $10.1M | $22.7M | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | $8.3M | -$1.4M | -$3.1M | $10.4M | $10.1M | $18.9M | 10-K 2026-03-25 |
| Q3 2025 2025-09-30 | $4.2M | -$4.6M | -$879K | $1.7M | $15.1M | $11.5M | 10-Q 2026-11-10 |
| Q2 2025 2025-06-30 | $3.7M | -$4.0M | -$1.4M | $2.0M | $10.1M | $8.3M | 10-Q 2026-08-12 |
| Q1 2025 2025-03-31 | $2.8M | -$11.1M | -$3.5M | $3.0M | $10.2M | $6.3M | 10-Q 2026-05-13 |
| Q4 2024 2024-12-31 | $847K | -$3.5M | -$1.2M | $1.2M | $9.9M | $4.9M | 10-K 2026-03-25 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-15 |
| Latest annual report | 10-K | 2026-03-25 |
| Latest quarterly / interim | 10-Q | 2026-11-10 |
| Latest current report | 8-K | 2026-11-12 |
| Latest proxy | DEF 14A | 2026-07-02 |
Source: SEC EDGAR submissions feed, 433 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -7.4% |
| 1 month | -23.3% |
| 3 months | -34.0% |
| Year to date | -69.2% |
| 1 year | -68.7% |
| From 52-week high | -75.2% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ECOR | electroCore Inc. | $4.84 | -7.81% | $44.7M |
| ITOC | iTonic Holdings Ltd | $1.88 | -5.05% | $13.8M |
| POCI | Precision Optics Corporation Inc. | $4.97 | -4.97% | $54.6M |
| IRIX | IRIDEX Corporation | $0.6878 | -0.32% | $12.1M |
| OM | Outset Medical Inc. | $3.39 | -9.12% | $64.0M |
| HYPR | Hyperfine Inc. | $0.6101 | -3.05% | $64.8M |
| NRXS | Neuraxis Inc. | $4.80 | -11.44% | $68.1M |
| STXS | Stereotaxis Inc. | $0.8027 | -4.80% | $80.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier